Sun Pharma launches generic Protonix tablets
Sun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is AB-rated to Wyeth's Protonix DR Tablets.
MUMBAI: Sun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is AB-rated to Wyeth's Protonix DR Tablets.
Sun's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories.
Sun Pharma had received a USFDA approval for these tablets in Sep 2007.
This strength of Pantoprazole Sodium has annual sales of around $2.3 billion in the US.
Sun's launch was initiated after the Dec 22, 2007 commercial launch by Teva Pharmaceutical Industries Ltd. of generic Pantoprazole Sodium tablet products, and after the Jan 29, 2008 commercial launch by Wyeth of generic Pantoprazole Sodium tablets product through its designated distributor.
Sun shares a 180-day period of marketing exclusivity with Teva for this product.
Sun is currently involved in patent litigation with Wyeth and Altana (now Nycomed) concerning this product in the US court of New Jersey. Although no trial date has yet been set, in Sep 2007, the court denied a motion filed by Wyeth and Altana for a preliminary injunction related to Sun's Pantoprazole tablets.
Wyeth and Altana have appealed the court's decision.
Sun's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories.
Sun Pharma had received a USFDA approval for these tablets in Sep 2007.
This strength of Pantoprazole Sodium has annual sales of around $2.3 billion in the US.
Sun's launch was initiated after the Dec 22, 2007 commercial launch by Teva Pharmaceutical Industries Ltd. of generic Pantoprazole Sodium tablet products, and after the Jan 29, 2008 commercial launch by Wyeth of generic Pantoprazole Sodium tablets product through its designated distributor.
Sun shares a 180-day period of marketing exclusivity with Teva for this product.
ADVERTISEMENT
Sun is currently involved in patent litigation with Wyeth and Altana (now Nycomed) concerning this product in the US court of New Jersey. Although no trial date has yet been set, in Sep 2007, the court denied a motion filed by Wyeth and Altana for a preliminary injunction related to Sun's Pantoprazole tablets.
Wyeth and Altana have appealed the court's decision.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
